EUDA Health announced that it will implement a reverse stock split of its ordinary shares at a ratio of 1-for-20. The reverse stock split was approved by the company’s board of directors in accordance with British Virgin Islands law. The reverse stock split will take effect at market open on March 23 and the ordinary shares will trade on a post-split basis on Nasdaq under the company’s existing trading symbol (EUDA) and will continue to trade under that symbol.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EUDA:
- EUDA Health price target lowered to $2.75 from $6 at Greenridge
- EUDA Health Repurchases Streeterville Warrant and Amends Charter to Clarify Share Actions
- EUDA Health announces repurchase, cancellation of Streeterville warrant
- EUDA Health Raises $3.75 Million and Retires Dilutive Warrant in February 2026 Capital Moves
